Detection of Antibodies Against SARS-Coronavirus Using Recombinant Truncated Nucleocapsid Proteins by ELISA

  • Lee, Hyun-Kyoung (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Lee, Byoung-Hee (Division of Vertebrates Research, National Institute of Biological Resources) ;
  • Dutta, Noton Kumar (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Seok, Seung-Hyeok (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Baek, Min-Won (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Lee, Hui-Young (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Kim, Dong-Jae (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Na, Yi-Rang (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Noh, Kyoung-Jin (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Park, Sung-Hoon (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Kariwa, Hiroaki (Laboratory of Public Health, Department of Environmental Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University) ;
  • Nakauche, Mina (Laboratory of Public Health, Department of Environmental Veterinary Sciences, Graduate School of Veterinary Medicine, Hokkaido University) ;
  • Mai, Le Quynh (Virology Department, National Institute of Hygiene and Epidemiology) ;
  • Heo, Suk-Jin (Biological Diagnostic Products Team, Bioogics Headquarters, Korea Food and Drug Administration) ;
  • Park, Jae-Hak (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul Nationla University)
  • Published : 2008.10.31

Abstract

Severe acute respiratory syndrome (SARS) is a life-threatening emerging respiratory disease caused by the coronavirus, SARS-CoV. The nucleocapsid (N) protein of SARS-CoV is highly antigenic and may be a suitable candidate for diagnostic applications. We constructed truncated recombinant N proteins (N1 [1-422 aa], N2 [1-109 aa], and N3 [110-422 aa]) and determined their antigenicity by Western blotting using convalescent SARS serum. The recombinants containing N1 and N3 reacted with convalescent SARS serum in Western blotting. However, the recombinant with N2 did not. In ELISA using N1 or N3 as the antigens, positive results were observed in 10 of to (100%) SARS-CoV-positive human sera. None of 50 healthy sera gave positive results in either assay. These data indicate that the ELISA using N1 or N3 has high sensitivity and specificity. These results suggest that the middle or C-terminal region of the SARS N protein is important for eliciting antibodies against SARS-CoV during the immune response, and ELISA reactions using N1 or N3 may be a valuable tool for SARS diagnosis.

Keywords

References

  1. Che, X. Y., L. W. Qiu, Z. Y. Liao, Y. D. Wang, K. Wen, Y. X. Pan, et al. 2005. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43. J. Infect. Dis. 191: 2033-2037 https://doi.org/10.1086/430355
  2. Dutta, N. K., K. Mazumdar, B. H. Lee, M. W. Baek, D. J. Kim, Y. R. Na, et al. 2008. Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine. Immunol. Lettl. 118: 65-71 https://doi.org/10.1016/j.imlet.2008.03.003
  3. Huang, L. R., C. M. Chiu, S. H. Yeh, W. H. Huang, P. R. Hsueh, W. Z. Yang, et al. 2004. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA. J. Med. Virol. 73: 338-346 https://doi.org/10.1002/jmv.20096
  4. Marra, M. A., S. J. M. Jones, C. R. Astell, R. A. Holt, A. Brooks-Wilson, Y. S. N. Butterfield, et al. 2003. The genome sequence of the SARS-associated coronavirus. Science 300: 1399-1404 https://doi.org/10.1126/science.1085953
  5. Reithinger, R., R. J. Quinnell, B. Alexander, and C. R. Davies. 2002. Rapid detection of Leishmania infantum infection in dogs: Comparative study using an immunochromatographic dipstick test, enzyme-linked immunosorbent assay, and PCR. J. Clin. Virol. 40: 2352-2356
  6. Rota, P. A., M. S. Oberste, S. S. Monroe, W. A. Nix, R. Campagnoli, J. P. Icenogle, et al. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300: 1394-1399 https://doi.org/10.1126/science.1085952
  7. Saijio, M., M. Nikura, S. Morikawa, T. G. Ksiazek, R. F. Meyer, C. J. Peters, and I. Kurane. 2001. Enzyme-linked immunosorbent assay for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. J. Clin. Virol. 39: 1-7 https://doi.org/10.1016/j.jcv.2007.02.004
  8. Saijo, M., T. Ogino, F. Taguchi, S. Fukushi, T. Mizutani, T. Notomi, et al. 2005. Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS. J. Virol. Methods 125: 181-186 https://doi.org/10.1016/j.jviromet.2005.01.028
  9. Shang, B., X. Y. Wang, J. W. Yuan, A. Vabret, X. D. Wu, R. F. Yang, et al. 2005. Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus. Biochem. Biophys. Res. Commun. 336: 110-117 https://doi.org/10.1016/j.bbrc.2005.08.032
  10. Shim, Y. Y., W. S. Shin, G. S. Moon, and K. H. Kim. 2007. Quantitative analysis of phosphinothricin-N-acetyltransferase in genetically modified herbicide tolerant pepper by an enzymelinked immunosorbent assay. J. Microbiol. Biotechnol. 17: 681-684
  11. Shin, G. C., Y. S. Chung, I. S. Kim, H. W. Cho, and C. Kang. 2006. Preparation and characterization of a novel monoclonal antibody specific to severe acute respiratory syndrome-coronavirus nucleocapsid protein. Virus Res. 122: 109-118 https://doi.org/10.1016/j.virusres.2006.07.004
  12. Sizun, J., D. Soupre, M. C. Legrand, J. D. Giroux, S. Rubio, J. M. Cauvin, C. Chastel, D. Alix, and L. de Parscau. 1995. Neonatal nosocomial respiratory infection with coronavirus: A prospective study in a neonatal intensive care unit. Acta Paediatr. 84: 617-620 https://doi.org/10.1111/j.1651-2227.1995.tb13710.x
  13. Sizun, J., M. W. Yu, and P. J. Talbot. 2000. Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: A possible source of hospital-acquired infections. J. Hosp. Infect. 46: 55-60 https://doi.org/10.1053/jhin.2000.0795
  14. Timani, K. A., L. Ye, L. Ye, Y. Zhu, Z. Wu, and Z. Gong. 2004. Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS. J. Clin. Virol. 30: 309-312 https://doi.org/10.1016/j.jcv.2004.01.001
  15. Wang, J., J. Wen, J. Li, J. Yin, Q. Zhu, H. Wang, et al. 2003. Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus. Clin. Chem. 49: 1989-1996 https://doi.org/10.1373/clinchem.2003.023184
  16. World Health Organization. 2003. WHO post-outbreak biosafety guidelines for handling of SARS-CoV specimens and cultures. Available at http://www.who.int/csr/sars/biosafety2003_12_18/en/
  17. Woo, P. C., S. K. Lau, B. H. Wong, K. H. Chan, W. T. Hui, G. S. Kwan, J. S. Peiris, R. B. Couch, and K. Y. Yuen. 2004. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J. Clin. Microbiol. 42: 5885-5888 https://doi.org/10.1128/JCM.42.12.5885-5888.2004
  18. Yu, F., M. Q. Le, S. Inoue, H. T. C. Thai, F. Hasebe, M. del Carmen Parquet, and K. Morita. 2005. Evaluation of inapparent nosocomial severe acute respiratory syndrome coronavirus infection in Vietnam by use of highly specific recombinant truncated nucleocapsid protein-based enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 12: 848-854